BULLET POINTS
=============

-   Pain perception in chronic LBP could be different depending on the country.

-   Spanish women present greater pain and poorer mental health than Spanish men do.

-   Spanish patients consider that LBP affects multidimensional contexts.

-   The potential relevance of cultural factors in chronic LBP must be determined.

Introduction
============

Low back pain (LBP) refers to symptoms located under the costal edge and above the folds of the lower gluteus muscles with or without irradiation to the leg[@B001]. LBP is classified as chronic when it persists for over 12 weeks[@B002]. Non-specific LBP is not attributed to any recognizable pathology (e.g., infection, tumor, osteoporosis, rheumatoid arthritis, fracture, or inflammation) and it is much more frequent than specific LBP derived from underlying medical conditions[@B002] ^,^ [@B003].

Pain is a complex perceptive disorder associated with social and cultural factors[@B004] ^,^ [@B005]. In fact, recognition of the pain experience is a complex subjective process with important psychosocial and cultural influences. In recent years, researchers have become highly interested in the effects of cultural factors[@B006] ^,^ [@B007], since these factors have acquired greater importance in chronic pain due to the biopsychosocial model[@B008] ^,^ [@B009].

Although no representative study provides an overall prevalence of LBP in Brazil[@B010], some studies have determined a prevalence of LBP in this country ranging from 4.2%[@B011] to 63%[@B012]. As an example, the prevalence of LBP in Pelotas, a medium-sized city of Brazil, has increased from 4.2% to 9.6% within the 2002-2010 period, in part due to an increase in life expectancy in this country[@B013]. Being a woman, smoker, and being married[@B013] have been identified as risk factors for LBP, whereas age, body mass index (BMI), exposure to repetitive movements, working in uncomfortable postures[@B013], and having sleep alterations are positively associated with LBP[@B014]. In Spain, the prevalence of LBP is around 20% and has remained unvaried in the last five-year period[@B015]. As in Brazil, LBP was associated with being a woman, increasing age, low educational level, low earning, and lack of physical activity[@B016].

Although it seems that cultural, social, and geographic factors play an important role in the development and persistence of LBP[@B017] and other musculoskeletal complaints[@B018], there are few studies investigating differences in LBP between Europe and South America, probably due to the difficulty in objectively measuring cultural impact in pain[@B019]. The research in this area observed medical, physical, and psychosocial differences among patients with LBP[@B020] and other musculoskeletal complaints[@B021] ^-^ [@B023] in different cultures, societies, and countries. Nevertheless, there is a lack of studies addressing the multi-dimensional features of the LBP presentation in this area[@B024].

Therefore, the main objective of the current study was to determine the differences in pain perception between individuals with LBP living in Brazil and Spain. The secondary objective was to determine the differences in health-related quality of life, disability, mood, and sleep quality between both countries and to identify the relations between demographic and clinical data in each country.

Method
======

Participants
------------

A cross-sectional design was used in this study. Thirty patients with LBP recruited from the Orthopedic Service at the São Carlos Health Unit (Brazilian Public Health Service) and 30 age- and sex-comparable individuals with LBP recruited from the Orthopedic Hospital Department at University-Hospital of Salamanca (Spanish Public Health Service) were included. Participants were recruited through consecutive sampling. To be eligible, they had to suffer from non-specific LBP without referral into the lower extremity for more than 6 months and diagnosed by an orthopedic physician. Exclusion criteria included: 1) age less than 18 years; 2) LBP with a specific underlying medical pathology such as tumor, infection, inflammatory disorders, disc problems, and nerve root compromise; 3) diagnosis of fibromyalgia syndrome; 4) previous lumbar spine surgery; 5) diagnosis of psychiatric illness; 6) presence of other musculoskeletal diagnosis at the time of the study; or 7) refusal to participate in the study. The medical history from each patient was requested from their primary care physician to assess the presence of the exclusion criteria. The same interviewer (DPRS), who was bilingual in Brazilian and Spanish languages and had 6 years of clinical experience, conducted the data collection in both countries. All of the questionnaires were self-administered.

All participants read and signed an informed consent form before their inclusion in the study. The current study was conducted following the Declaration of Helsinki and was approved by the Ethics Committee of the University of Salamanca, Salamanca, Spain (code number: 7/2-12). In addition, clinical services of both countries accepted these ethical considerations following an international ethical agreement between both countries.

Pain outcomes
-------------

An 11-point numerical pain rating scale (NPRS, 0: no pain; 10: maximum pain) was used to assess the mean intensity of pain experienced in the last week[@B025]. Differences below 1.5 points in the NPRS are not considered clinically relevant[@B026]. Patients were also asked about the duration of pain symptoms.

The McGill Pain Questionnaire (MPQ) was used to assess pain intensity. Items were joined to achieve three main domains of the questionnaire, i.e., sensory (1-15), affective (16-18), and evaluative (19), as well as the total score or pain rating index (PRI) for each domain. We also considered the number of words chosen by the patient (NWC) and the present pain index (PPI), which describes current pain intensity from 0 (no pain) to 5 (excruciating pain) scales. In the current study, we used the Spanish[@B027] and the Brazilian[@B028] versions of the questionnaire, which have shown good validity. A 30% difference is generally considered clinically meaningful[@B029].

Oswestry Disability Index (ODI)
-------------------------------

The ODI is one of the most frequently used tools for measuring LBP-related disability[@B030] ^,^ [@B031]. The ODI contains 10 questions (rated from 0 to 5 points each) about daily activities, including inventories of pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sexual life, social life, and traveling. The ODI scores range from 0 to 100. Higher scores indicate greater disability. The ODI was validated for LBP and it presents high reliability and consistency (ICC=0.99, α=0.87)[@B032]. In the current study, we also used the Brazilian[@B033] ^,^ [@B034] and Spanish[@B035] adapted versions of this questionnaire. It has been determined that a minimal clinically important difference (MCID) of the ODI is a difference of 10 points and more than 30%[@B029].

Health-related quality of life
------------------------------

The health-related quality of life was assessed with the Medical Outcomes Study Short Form 36 (SF-36) questionnaire, which assessed eight domains: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health[@B036]. After adding the Likert-scaled items, each scale is standardized, so that it ranges from 0 (lowest level of functioning) to 100 (highest level)[@B037]. Again, the Spanish[@B038] and Brazilian[@B039] adaptations were used.

The SF-36 questionnaire can be also summarized as two health measures: physical component score (PCS) and mental component score (MCS). The PCS is derived from the following domains (physical function, physical role, bodily pain, and general health), whereas the MCS is derived from emotional role, social function, mental health, and vitality domains[@B040]. In the current study, we considered physical and mental components of the SF36 questionnaire for the main analysis. As recommended by the IMMPACT group, a 30% change could be used as a barometer of positive clinical difference[@B041].

Beck Depression Inventory-II (BDI-II)
-------------------------------------

Participants also completed the Beck Depression Inventory-II (BDI-II), a 21-item self-report questionnaire that assesses affective, cognitive, and somatic symptoms of depression[@B042]. The BDI-II showed good internal consistency (α=0.83) and test-retest reliability (0.68-0.89)[@B042]. The Spanish[@B043] and Brazilian[@B044] versions have also shown good internal consistency. The MCID of the BDI-II is 17.5%[@B045].

Sleep quality assessment
------------------------

The Pittsburgh Sleep Quality Index (PSQI) is the most commonly used tool for a comprehensive assessment of sleep quality[@B046]. The PSQI appraises sleep quality over a one-month period through a questionnaire differentiating between good and poor sleepers. It includes 19 self-rated questions and 5 questions answered by bedmates/roommates. The items use varying response categories that include recording usual bed time, usual wake time, number of actual hours slept, and number of minutes to fall asleep, as well as forced-choice Likert-type responses (0-3). The sum of the scores for the components yields one global score, which ranges from 0 to 21, where higher scores indicate worse sleep quality[@B047]. A total score \>8.0 indicates poor sleep quality[@B047]. Buysse et al. [@B047] reported that the PSQI has good internal consistency (α=0.83) and test-retest reliability (r=0.85). The Brazilian[@B048] and Spanish[@B049] versions were used. No MCID data available for the PSQI.

Sample size calculation
-----------------------

The sample size determination was performed using the Spanish software Ene 3.0 (Glaxo Smith Kline, Universidad Autónoma, Barcelona, Spain). The calculations were based on detecting clinical differences of 10 points in the ODI and standard deviation of 13 points[@B029] between groups, with a bilateral significance level of 0.05 and power of 0.80. This generated a sample size of at least 28 patients in each group.

Statistical analysis
--------------------

Data were analyzed with the statistical package SPSS version 21.0 (SPSS Inc., Chicago, IL, USA). Descriptive data were collected for all patients. The Kolmogorov-Smirnov test was used to analyze the normal distribution of the variables. Quantitative data without a normal distribution (BDI and MCS) were analyzed with nonparametric tests, and the remaining data with normal distribution were analyzed with parametric tests. Differences in the quantitative variables between countries were assessed with the unpaired Student-t test and the nonparametric Mann-Whitney U-test. The chi-square (χ2) test was used to analyze differences in sex between both groups. A 2-way analysis of variance (ANOVA) test was used to investigate the differences in outcomes with country (Brazil or Spain) and gender (men or women) as the between-subjects factors. The Pearson (r) test and Spearman's rho (rs) test were used to determine the correlations between demographic and clinical variables in each country. The strength of the correlations was classified as weak (r from 0.1 to 0.3), moderate (r from 0.4 to 0.6), or strong (r from 0.7 to 1)[@B050]. The statistical analysis was conducted at 95% confidence level.

Results
=======

Differences in demographic and clinical data by country and by gender
---------------------------------------------------------------------

No significant differences between patients of either country were observed for age (P=0.64), gender distribution (P=0.80, weight (P=0.14), height (P=0.06), BMI (P=0.85), years with pain (P=0.74), pain intensity (P=0.24), PPI (P=0.92), PRI total score (P=0.72), or NWC (P=0.11). On the other hand, we found greater disability in Spanish patients than in Brazilian people (mean difference MD, 95%CI: 9.87, 18.06-1.68), P=0.02). [Table 1](#t01){ref-type="table"} summarizes demographic and clinical data of Spanish and Brazilian patients with LBP.

###### Demographic and clinical data of Brazilian and Spanish patients with low back pain (LBP).

                                                              **Brazilian (n=30)**      **Spanish (n=30)**         **Significance**
  ----------------------------------------------------------- ------------------------- -------------------------- --------------------
  **Gender (male/female)**                                    13 / 17                   14 / 16                    X^2^=0.07; P=0.795
  **Age (years)**                                             49.7±10.5 (45.8-53.6)     51.1±13 (46.3-56)          t=-0.469; P=0.641
  **Weight (kg)**                                             74±7.5 (71.2-76-8)        76.8±6.5 (74.4-79.2)       t=-1.515; P=0.135
  **Height (cm)**                                             165.4±0.1 (162.8-167.9)   169±0.1 (166.3-171.7)      t=-2.003; P=0.06
  **BMI (kg/cm^2^)**                                          27.1±2.6 (26.1-28.1)      27.0±2.8 (25.9-28)         t=0.188; P=0.852
  **Time suffering pain (months)**                            117.6±94.7 (82.2-152.9)   125.9±102.6 (87.6-164.2)   t=-0.328; P=0.744
  **Current pain intensity (NPRS, 0-10)**                     7.1±1.6 (6.5-7.7)         6.4±2.5 (5.5-7.4)          t=1.185; P=0.241
  **PPI (MPQ, 0-5)**                                          3.1±1.1 (2.7-3.5)         3.1±1.4 (2.6-3.6)          t=0.1; P=0.921
  **PRI total score (MPQ, 0-100)**                            41.3±15.9 (35.4-47.3)     43.2±23.6 (34.3-52)        t=-0.357; P=0.723
  **NWC (MPQ, 0-20)**                                         14.2±3.9 (12.8-15.7)      12.3±5.1 (10.4-14.2)       t=1.641; P=0.107
  **PCS (SF-36, 0-100)** [^\*^](#TFN1){ref-type="table-fn"}   59.6±20.7 (51.9-67.3)     42.5±22.2 (34.3-50.8)      t=3.081; P=0.001
  **MCS (SF-36, 0-100)**                                      70.5±16.7 (64.2-76.7)     62.6±21.1 (54.8-70.5)      z=-1.02; P=0.308
  **ODI score (0-100)** [^\*^](#TFN1){ref-type="table-fn"}    24.4±13.3 (19.4-29.4)     34.3±18 (27.5-41)          t=-2.411; P=0.019
  **BDI score (0-63)**                                        9.5±5.8 (7.4-11.6)        11.1±9.4 (7.6-14.6)        z=-0.03; P=0.976
  **PSQI score (0-21)**                                       8±2.3 (7.1-8.9)           7.9±4.4 (6.3-9.6)          t=0.073; P=0.942

Data are expressed as means ± standard deviation (95% Confidence Interval); BMI: Body Mass Index; PPI: Present Pain Index; NWC: Number of Words Chosen; PRI: Pain Rating Index; PCS: Physical Component Summary; MCS: Mental Component Summary; ODI: Oswestry Disability Index; BDI: Beck Depression Inventory; PSQI: Pittsburgh Sleep Quality Index.

Indicates statistically significant difference between groups.

The ANOVA revealed a significant Country \* Gender interaction for PRI total score (P=0.04), but not for intensity of pain (P=0.88), disability (P=0.35), PPI (P=0.75), or NWC (P=0.06). Spanish women with LBP exhibited greater pain ratio than Spanish men (MD, 95%CI: 18.06, 3.84-32.28, P=0.01), whereas no gender differences were found in Brazilians. [Table 2](#t02){ref-type="table"} shows demographic and clinical data of Spanish and Brazilian patients with LBP by gender.

###### Clinical data of Brazilian and Spanish patients with low back pain (LBP) by gender.

                                                                        **Brazilian**           **Spanish**                                     
  --------------------------------------------------------------------- ----------------------- ----------------------- ----------------------- -----------------------
  **Current pain (NPRS, 0-10)**                                         7.5±1.7 (6.5-8.5)       6.6±1.3 (5.4-7.7)       6.9±2.4 (5.9-8.0)       5.9±2.6 (4.7-7.0)
  **PPI (MPQ, 0-5)**                                                    3.2±1.1 (2.7-3.8)       3.0±1.2 (2.3-3.7)       3.3±1.5 (2.5-4.1)       2.9±1.4 (2.1-3.6)
  **PRI total score (MPQ, 0-100)** [^\*^](#TFN2){ref-type="table-fn"}   39.9±21.1 (30.5-49.3)   43.2±18.2 (32.4-54.0)   51.6±22.1 (41.9-61.3)   33.6±22.4 (23.2-43.9)
  **NWC (MPQ, 0-20)**                                                   14.2±4.3 (12.0-16.4)    14.2±3.6 (12.1-16.4)    14.3±4.7 (11.8-16.8)    10.0±4.7 (7.3-12.7)
  **PCS (SF-36, 0-100)**                                                62.1±20.7 (51.7-72.5)   56.4±21.1 (44.5-68.3)   37.8±20.0 (27.1-48.5)   48.0±24.0 (36.5-59.4)
  **MCS (SF-36, 0-100)** [^\*^](#TFN2){ref-type="table-fn"}             73.0±17.2 (64.2-81.9)   67.1±16.1 (56.9-77.2)   54.8±21.5 (45.6-63.9)   71.6±17.2 (61.9-81.4)
  **ODI score (0-100)**                                                 24.2±15.2 (16.5-31.9)   24.7±10.9 (15.9-33.5)   37.7±14.6 (29.7-45.7)   30.4±21.1 (21.8-38.9)
  **BDI score (0-63)** [^\*^](#TFN2){ref-type="table-fn"}               8.5±6.7 (4.9-12.0)      10.9±4.1 (6.8-14.9)     14.9±9.6 (11.3-18.6)    6.6±7.1 (2.8-10.5)
  **PSQI score (0-21)** [^\*^](#TFN2){ref-type="table-fn"}              7.9±2.6 (6.3-9.6)       8.1±1.9 (6.2-10.0)      9.5±4.2 (7.8-11.2)      6.1±4.1 (4.3-8.0)

Data are expressed as means ± standard deviation (95% Confidence Interval); BMI: Body Mass Index; PPI: Present Pain Index; NWC: Number of Words Chosen; PRI: Pain Rating Index; PCS: Physical Component Summary; MCS: Mental Component Summary; ODI: Oswestry Disability Index; BDI: Beck Depression Inventory; PSQI: Pittsburgh Sleep Quality Index.

Indicated statistically significant group by gender interaction.

Quality of life
---------------

Significant differences between countries were observed for physical (MD, 95%CI: 17.06, 5.98-28.15, P\<0.01) but not for mental (P=0.31) component scores of the SF36 questionnaire: Spanish patients exhibited lower physical quality of life than Brazilian patients ([Table 1](#t01){ref-type="table"}). When gender was included, the ANOVA found a significant Country \* Gender interaction for the MCS (P=0.02), but not for the PCS (P=0.16). Spanish women exhibited lower MCS than Spanish men (MD, 95%CI: 16.87, 3.49-30.24) and Brazilian men (MD, 95%CI: 12.31, 0.46-25.08) and women (MD, 95%CI: 18.26, 5.53-30.99) ([Table 2](#t02){ref-type="table"}).

Depression and sleep quality
----------------------------

No significant differences between countries were observed for depressive symptoms (P=0.98) or sleep quality (P=0.94) ([Table 1](#t01){ref-type="table"}). When gender was included, the ANOVA revealed significant Country \* Gender interactions for both depression (P=0.01) and sleep quality (P=0.04). Again, Spanish women exhibited higher levels of depression and worse sleep quality than Spanish men did (BDI: MD, 95%CI: 8.30, 2.96-13.63; PSQI: 3.36, 0.87-5.85) and Brazilian women (BDI: MD, 95%CI: 6.47, 1.39-11.55; PSQI: 1.6, 0.11-3.13) ([Table 2](#t02){ref-type="table"}).

Correlations between demographic and clinical data by country
-------------------------------------------------------------

Significant positive correlations were found between age and BMI, ODI, NPRS, PRI, and PPI in Brazilian, but not Spanish, patients with LBP. Within Brazilian patients, the older the patients were, the greater the BMI, disability, and pain intensity. Age was negatively associated with PCS in Brazilian, but not Spanish, patients. The older the patients were, the lower the physical component of quality of life ([Tables 3](#t03){ref-type="table"} and [4](#t04){ref-type="table"}).

###### Correlations between demographic and clinical data within Spanish patients with low back pain (LBP).

  **(n=30)**   **Age**   **BMI**                                     **PSQI**                                      **ODI**                                       **NPRS**                                    **PRI**                                       **NWC**                                       **PPI**   **BDI**                                       **PCS**
  ------------ --------- ------------------------------------------- --------------------------------------------- --------------------------------------------- ------------------------------------------- --------------------------------------------- --------------------------------------------- --------- --------------------------------------------- -------------------------------------------
  **BMI**      0.267                                                                                                                                                                                                                                                                                                                                             
  **PSQI**     0.023     0.308                                                                                                                                                                                                                                                                                                                                   
  **ODI**      0.215     0.016                                       0.461[^\*^](#TFN3){ref-type="table-fn"}                                                                                                                                                                                                                                                     
  **NPRS**     --0.201   --0.387[^\*^](#TFN3){ref-type="table-fn"}   0.364[^\*^](#TFN3){ref-type="table-fn"}       0.427[^\*^](#TFN3){ref-type="table-fn"}                                                                                                                                                                                                       
  **PRI**      --0.205   --0.274                                     0.486[^\*\*^](#TFN4){ref-type="table-fn"}     0.621[^\*\*^](#TFN4){ref-type="table-fn"}     0.743[^\*\*^](#TFN4){ref-type="table-fn"}                                                                                                                                                       
  **NWC**      --0.233   --0.174                                     0.553[^\*\*^](#TFN4){ref-type="table-fn"}     0.583[^\*\*^](#TFN4){ref-type="table-fn"}     0.600[^\*\*^](#TFN4){ref-type="table-fn"}   0.919[^\*\*^](#TFN4){ref-type="table-fn"}                                                                                                           
  **PPI**      0.005     --0.158                                     0.349                                         0.374[^\*^](#TFN3){ref-type="table-fn"}       0.592[^\*\*^](#TFN4){ref-type="table-fn"}   0.599[^\*\*^](#TFN4){ref-type="table-fn"}     0.480[^\*\*^](#TFN4){ref-type="table-fn"}                                                             
  **BDI**      0.271     --0.056                                     0.458[^\*^](#TFN3){ref-type="table-fn"}       0.597[^\*\*^](#TFN4){ref-type="table-fn"}     0.324                                       0.622[^\*\*^](#TFN4){ref-type="table-fn"}     0.694[^\*\*^](#TFN4){ref-type="table-fn"}     0.179                                                   
  **PCS**      --0.306   0.006                                       --0.313                                       --0.611[^\*\*^](#TFN4){ref-type="table-fn"}   --0.259                                     --0.426[^\*^](#TFN3){ref-type="table-fn"}     --0.421\*                                     --0.159   --0.664[^\*\*^](#TFN4){ref-type="table-fn"}   
  **MCS**      --0.252   --0.179                                     --0.508[^\*\*^](#TFN4){ref-type="table-fn"}   --0.574[^\*\*^](#TFN4){ref-type="table-fn"}   --0.372[^\*^](#TFN3){ref-type="table-fn"}   --0.576[^\*\*^](#TFN4){ref-type="table-fn"}   --0.664[^\*\*^](#TFN4){ref-type="table-fn"}   --0.285   --0.752[^\*\*^](#TFN4){ref-type="table-fn"}   0.767[^\*\*^](#TFN4){ref-type="table-fn"}

Values are expressed as Pearson's *r* or Spearman's rho; NS: not significant.

P\<0.05.

P\<0.01.

###### Correlations between demographic and clinical data within Brazilian patients with low back pain (LBP).

  **(n=30)**   **Age**                                       **BMI**                                   **PSQI**                                    **ODI**                                       **NPRS**   **PRI**                                     **NWC**                                   **PPI**                                       **BDI**                                       **PCS**
  ------------ --------------------------------------------- ----------------------------------------- ------------------------------------------- --------------------------------------------- ---------- ------------------------------------------- ----------------------------------------- --------------------------------------------- --------------------------------------------- -------------------------------------------
  **BMI**      0.490[^\*\*^](#TFN6){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                      
  **PSQI**     0.153                                         0.011                                                                                                                                                                                                                                                                                                                            
  **ODI**      0.681[^\*\*^](#TFN6){ref-type="table-fn"}     0.364[^\*^](#TFN5){ref-type="table-fn"}   0.123                                                                                                                                                                                                                                                                                  
  **NPRS**     0.428[^\*^](#TFN5){ref-type="table-fn"}       0.196                                     0.311                                       0.587[^\*\*^](#TFN6){ref-type="table-fn"}                                                                                                                                                                                                  
  **PRI**      0.437[^\*^](#TFN5){ref-type="table-fn"}       0.098                                     0.268                                       0.473[^\*\*^](#TFN6){ref-type="table-fn"}     0.328                                                                                                                                                                                        
  **NWC**      0.25                                          0.057                                     0.072                                       0.448[^\*^](#TFN5){ref-type="table-fn"}       0.307      0.766[^\*\*^](#TFN6){ref-type="table-fn"}                                                                                                                                         
  **PPI**      0.435[^\*^](#TFN5){ref-type="table-fn"}       0.093                                     0.161                                       0.522[^\*\*^](#TFN6){ref-type="table-fn"}     0.336      0.297                                       0.191                                                                                                                                 
  **BDI**      0.216                                         0.086                                     0.138                                       0.399[^\*^](#TFN5){ref-type="table-fn"}       0.188      0.354                                       0.431[^\*^](#TFN5){ref-type="table-fn"}   0.099                                                                                       
  **PCS**      --0.567[^\*\*^](#TFN6){ref-type="table-fn"}   --0.181                                   --0.354                                     --0.643[^\*\*^](#TFN6){ref-type="table-fn"}   -0.304     --0.428[^\*^](#TFN5){ref-type="table-fn"}   --0.27                                    --0.615[^\*\*^](#TFN6){ref-type="table-fn"}   --0.393[^\*^](#TFN5){ref-type="table-fn"}     
  **MCS**      --0.132                                       --0.100                                   --0.385[^\*^](#TFN5){ref-type="table-fn"}   --0.248                                       0.050      --0.203                                     --0.191                                   --0.202                                       --0.504[^\*\*^](#TFN6){ref-type="table-fn"}   0.655[^\*\*^](#TFN6){ref-type="table-fn"}

Values are expressed as Pearson's *r* or Spearman's rho; NS: not significant.

P\<0.05.

P\<0.01.

The Spanish group showed a consistent pattern of correlations for clinical data, where all variables were significantly related to each other, with a few exceptions including PSQI to PCS, NPRS to BDI and PCS, and PPI to PSQI. All correlation coefficients were considered moderate or high ([Table 3](#t03){ref-type="table"}).

In contrast, within Brazilian patients, the correlation pattern depended on the outcome. Thus, the ODI was the only variable related to all of the others, with the exception of the MCS: the greater the disability was, the worse the pain intensity, sleep, physical quality of life, and mood. The PCS also showed negative correlations with PRI, PPI, BDI, and MCS: the worse the physical aspect of quality of life, the worse pain intensity, mood, or sleep quality. In general, correlations within Brazilian patients were lower than those in the Spanish group ([Table 4](#t04){ref-type="table"}).

Discussion
==========

The results of the current study show that pain perception in patients with LBP can be affected in some aspects depending on the country of residence. We observed that the country of origin and gender do not determine a different pattern of behavior for physical quality of life and disability; however, the mental quality of life and mood of Spanish women suffering from LBP was appreciably worse than those of Brazilian men and women and Spanish men. Further, the correlation patterns seen in Spanish patients suggest that LBP could be a global phenomenon affecting several components of the subject's life, whereas this correlation is less clear for Brazilians, at least for the studied sample.

Between-countries differences
-----------------------------

Pain intensity did not show significant differences between the two countries. In fact, differences in the NPRS did not achieve the threshold to be considered clinically relevant[@B026]. In contrast, Spanish individuals exhibited statistically significant and clinically higher levels of disability than Brazilians, with differences above the MCID[@B029]. This higher self-rated perception of disability in Spain may be associated with sedentary lifestyle[@B015] or a social security system associated with job absenteeism[@B051]. This assumption is supported in other northern European countries where these factors have been associated with development and persistence of LBP[@B007].

Our sample of Spanish patients reported a similar physical health-related quality of life status than in other countries[@B052]; nonetheless, the physical, but not mental, quality of life of Spanish patients was worse than that of Brazilians.

No differences in depressive levels were observed between Brazilian and Spanish patients with LBP. The prevalence of depression in patients with LBP is high[@B053], suggesting that this psychological state may involve common mechanisms with chronic pain[@B054]. Nevertheless, we should recognize that our patients with LBP exhibited lower levels of depression (9\<BDI-II\<11). We do not know if the presence of higher depressive levels would show between-countries differences.

In addition, Brazilian and Spanish patients with LBP exhibited similar patterns of sleep quality. In our study, most of the patients showed around 8 points suggesting that both populations exhibited poor sleep quality[@B055]. Our results agree with previous studies supporting that people with LBP have poor sleep quality and high levels of insomnia[@B056] ^,^ [@B057]. The relationship between pain and sleep disorders is bidirectional since sleep disturbances may increase pain, but pain may also cause sleep disorders[@B058]. Thus, the lack of sleep may interfere with pain processing[@B059].

Gender
------

It is well accepted that gender is a relevant factor in the modulation of pain, and there is a considerable body of evidence suggesting that women have more frequent LBP[@B060] ^-^ [@B062], higher levels of disability[@B063], a and higher number of comorbidities[@B064] than men.

In the current study, gender was a differentiating factor between countries in some outcomes. For instance, although the intensity of LBP and the NWS did not reveal differences by gender and country, Spanish women reported higher PRI[@B029] ^,^ [@B065] than Spanish men whereas Brazilian women and men had similar values. There is evidence that culture/race interacts with gender in the pain experience[@B066] ^,^ [@B067] and this influence is modulated by the country in which the subject grows up. It has been also described that perceived disability may differ according to gender[@B068] ^,^ [@B069] since women are more likely to experience disability than men[@B063]. However, we did not observe differences in self-perceived disability between men and women in either country. Nevertheless, more research is needed to determine why chronic pain is more likely to be disabling for women than for men[@B054].

We observed that Spanish women reported worse mental, but not physical, health status than Brazilian women and Spanish men. These data are partly in agreement with those of other authors, in which Italian women also reported poorer mental and physical health[@B052]. In this study, Italian men separated pain from purely physical deterioration, showing that LBP has important mental health repercussions. Again, it is reported that women have more co-morbid mood disorders[@B070], more co-morbid physical conditions[@B071], and a higher number of somatic symptoms[@B072] than men do. In our study, this profile may have only applied to Spanish women, who displayed the worst depressive state and greatest sleep disorders than the rest of the subjects.

Different theories are proposed to explain gender differences in pain perception. First, biological factors may interfere in the greater frequency of chronic pain in women[@B073] ^,^ [@B074]. Second, regarding interference in social functions, women may perceive the painful event as a threat owing to the multiple roles and responsibilities they are charged with, such as child and elderly care, household management, and job[@B062], even though women are considered more resistant to expressing their pain[@B060] and more emotional than men[@B075]. By contrast, men may downplay their own pain, highlighting that insensitivity or resistance to pain is a sign of masculine virility[@B060] ^,^ [@B069]. These hypotheses clearly reflect the cultural influence on the experience of pain.

Self-perception of the pain condition
-------------------------------------

We tried to determine the potential global self-perception of the condition by investigating the correlation between different outcomes. We found several correlations within Spanish patients with LBP that were less significant in Brazilian people. These findings indicate that LBP seems to be considered a global condition by Spanish people with several domains affected to the same extent, as previously described[@B076]. The relationships observed within Spanish patients agree with previous findings, i.e., patients' quality of life more dependent on the degree of disability they self-perceived than the actual pain intensity[@B077] ^,^ [@B078]. Therefore, the study of a multidimensional set of factors, i.e., quality of life, mood, and sleep, would be more important than the study of pain itself.

According to our results, when dealing with LBP it seems necessary to include the social and cultural aspects in the clinical context since this may offer an improvement in the therapeutic approach and the long-term clinical results.

Limitations
-----------

We should recognize some potential limitations in the current study. First, the sample size can be considered small, which could decrease the power of multiple comparisons; however, our main objective was not to conduct a population-based study. Future studies including more representative populations are now needed to determine the influence of cultural factors on LBP. Secondly, the clinical heterogeneity of the patients could also influence the results. Further, social variables were neither collected nor studied, which limits the applicability of the results. Third, we did not collect outcomes on catastrophism or kinesiophobia, two clinical topics relevant to patients with LBP. Finally, the questionnaires used in the study were not specific for LBP patients, with the exception of the ODI. Other questionnaires could afford new perspectives on the results.

Conclusions
===========

This study showed that pain perception in patients with LBP is affected in some aspects depending on the country of residence. We found that Spanish women reported greater pain index, poorer mental health, poorer mood, and a poorer quality of life than Spanish men and Brazilian patients. No differences in pain intensity and disability were observed. The level of relationships between pain, disability, quality of life, mood, and sleep patterns was significantly higher in Spanish patients with LBP, suggesting that this condition is considered a global entity affecting multidimensional contexts within Spanish patients. Future population-based studies are needed to determine the potential relevance of cultural factors in patients with LBP.
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